Skip to main content

Table 2 Co-Morbidities of 1,123 Patients Hospitalized With COVID-19

From: COVID-19 clinical outcomes and nationality: results from a Nationwide registry in Kuwait

 

Kuwaiti (N = 294)

Non-Kuwaiti (N = 829)

Overall (N = 1123)

Any comorbidity

 At least one comorbidity

140 (47.6%)

214 (25.8%)

354 (31.5%)

 No comorbidities

154 (52.4%)

615 (74.2%)

769 (68.5%)

Hypertension

 No

213 (72.4%)

721 (87.0%)

934 (83.2%)

 Yes

81 (27.6%)

108 (13.0%)

189 (16.8%)

Diabetes

 No

227 (77.2%)

728 (87.8%)

955 (85.0%)

 Yes

67 (22.8%)

101 (12.2%)

168 (15.0%)

Asthma

 No

269 (91.5%)

806 (97.2%)

1075 (95.7%)

 Yes

25 (8.5%)

23 (2.8%)

48 (4.3%)

Total Comorbiditya

 0

154 (52.4%)

615 (74.2%)

769 (68.5%)

 1

55 (18.7%)

132 (15.9%)

187 (16.7%)

 2

38 (12.9%)

57 (6.9%)

95 (8.5%)

 3

30 (10.2%)

19 (2.3%)

49 (4.4%)

 4

14 (4.8%)

6 (0.7%)

20 (1.8%)

 5

2 (0.7%)

0 (0%)

2 (0.2%)

 6

1 (0.3%)

0 (0%)

1 (0.1%)

  1. aComorbidities were diabetes mellitus, hypertension, coronary artery disease/ischemic heart disease, chronic obstructive pulmonary disease, asthma, cerebrovascular disease, hepatitis, dyslipidemia, cancer, hypothyroidism, chronic renal disease, immunodeficiency, recent surgery (during the past 30 days), pregnancy, and other